Genetic Screens Identify a Context-Specific PI3K/p27Kip1 Node Driving Extrahepatic Biliary Cancer

Chiara Falcomatà(German Cancer Research Center), Stefanie Bärthel(German Cancer Research Center), Angelika Ulrich(German Cancer Research Center), Sandra Diersch(TUM Klinikum), Christian Veltkamp(German Cancer Research Center), Lena Rad(German Cancer Research Center), Fabio Boniolo(German Cancer Research Center), Myriam Solar(Cancer Research UK Scotland Institute), Katja Steiger(German Cancer Research Center), Barbara Seidler(German Cancer Research Center), Magdalena Żukowska(German Cancer Research Center), Joanna Madej(German Cancer Research Center), Mingsong Wang(German Cancer Research Center), Rupert Öllinger(German Cancer Research Center), Roman Maresch(German Cancer Research Center), Maxim Barenboim(German Cancer Research Center), Stefan Eser(German Cancer Research Center), Markus Tschurtschenthaler(German Cancer Research Center), Arianeb Mehrabi(Heidelberg University), Stéphanie Roessler(Heidelberg University), Benjamin Goeppert(Heidelberg University), Alexander Kind(Technical University of Munich), Angelika Schnieke(Technical University of Munich), María S. Robles(LMU Klinikum), Allan Bradley(Wellcome Sanger Institute), Roland M. Schmid(TUM Klinikum), Marc Schmidt‐Supprian(German Cancer Research Center), Maximilian Reichert(German Cancer Research Center), Wilko Weichert(German Cancer Research Center), Owen J. Sansom(Cancer Research UK Scotland Institute), Jennifer P. Morton(Cancer Research UK Scotland Institute), Roland Rad(German Cancer Research Center), Günter Schneider(German Cancer Research Center), Dieter Saur(German Cancer Research Center)
Cancer Discovery
July 19, 2021
Cited by 20Open Access
Full Text

Abstract

Biliary tract cancer ranks among the most lethal human malignancies, representing an unmet clinical need. Its abysmal prognosis is tied to an increasing incidence and a fundamental lack of mechanistic knowledge regarding the molecular basis of the disease. Here, we show that the Pdx1-positive extrahepatic biliary epithelium is highly susceptible toward transformation by activated PIK3CAH1047R but refractory to oncogenic KrasG12D. Using genome-wide transposon screens and genetic loss-of-function experiments, we discover context-dependent genetic interactions that drive extrahepatic cholangiocarcinoma (ECC) and show that PI3K signaling output strength and repression of the tumor suppressor p27Kip1 are critical context-specific determinants of tumor formation. This contrasts with the pancreas, where oncogenic Kras in concert with p53 loss is a key cancer driver. Notably, inactivation of p27Kip1 permits KrasG12D-driven ECC development. These studies provide a mechanistic link between PI3K signaling, tissue-specific tumor suppressor barriers, and ECC pathogenesis, and present a novel genetic model of autochthonous ECC and genes driving this highly lethal tumor subtype. SIGNIFICANCE: We used the first genetically engineered mouse model for extrahepatic bile duct carcinoma to identify cancer genes by genome-wide transposon-based mutagenesis screening. Thereby, we show that PI3K signaling output strength and p27Kip1 function are critical determinants for context-specific ECC formation. This article is highlighted in the In This Issue feature, p. 2945.


Related Papers

No related papers found

Powered by citation graph analysis